Report cover image

Celiac Disease Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

Publisher BIS Research
Published Sep 18, 2025
SKU # BIS20409803

Description

Global Celiac Disease Market, Analysis and Forecast: 2025-2035

The global celiac disease market is witnessing significant growth, fueled by rising awareness of gluten-related disorders, increasing prevalence of celiac disease, and advancements in diagnostic and therapeutic options. Celiac disease, an autoimmune disorder triggered by gluten ingestion, affects millions worldwide, with growing diagnosis rates particularly in the U.S., Europe, and Asia-Pacific regions. The global celiac disease market is evolving as pharmaceutical companies and food manufacturers focus on developing effective treatment modalities and gluten-free product offerings to meet patient needs.

The celiac disease market is driven by the expanding adoption of gluten-free diets, emerging pharmacological therapies, and improvements in diagnostic technologies that enable early and accurate detection. Increased healthcare expenditure and improved patient education in key markets such as the U.S., U.K., and Germany contribute substantially to the market’s upward trajectory. Moreover, growing clinical research on novel drug candidates and enzyme-based therapies supports the development of targeted treatments designed to improve patient outcomes and quality of life.

A critical factor propelling the global celiac disease market is the rising incidence of autoimmune diseases and heightened screening efforts, particularly among genetically predisposed populations. The market benefits from ongoing innovation in gluten-free food products that address nutritional deficiencies and enhance palatability, which improves patient adherence to dietary restrictions.

Despite these promising developments, the celiac disease market faces challenges such as high costs associated with gluten-free products and limited availability in developing regions. Additionally, the lack of definitive pharmacological cures and regulatory complexities for emerging therapies restricts market penetration. Social stigma and patient hesitancy toward diagnosis and treatment also impact market expansion in certain geographies.

The competitive landscape of the global celiac disease market remains dynamic, with key players including Takeda Pharmaceutical Company Limited, Immunic Therapeutics, and Pfizer actively investing in research and development. Strategic partnerships, mergers, and acquisitions are common as companies aim to strengthen their product pipelines and enhance market reach. Increasing focus on personalized medicine and innovative drug delivery platforms is anticipated to drive future growth and intensify competition within the market.

The global celiac disease market will maintain momentum with an emphasis on novel drug development, improved dietary interventions. Investment in precision medicine and increased accessibility to gluten-free products are poised to shape the market’s future, positioning the celiac disease market as a vital segment within autoimmune and gastrointestinal disorder therapeutics.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

Table of Contents

Executive Summary
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note
1. Global Celiac Disease Market: Industry Analysis
1.1 Market Overview and Ecosystem
1.2 Epidemiological Analysis
1.3 Key Market Trends
1.3.1 Impact Analysis
1.4 Patent Analysis
1.4.1 Patent Filing Trend (by Country)
1.4.2 Patent Filing Trend (by Year)
1.5 Regulatory Landscape
1.6 Ongoing Clinical Trials
1.7 Market Dynamics
1.7.1 Market Drivers
1.7.2 Market Restraints
1.7.3 Market Opportunities
2. Global Celiac Disease Market, by Region, $Million, 2023-2035
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Celiac Disease Market, by Country
2.1.2.1.1 U.S.
2.1.2.1.2 Canada
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Celiac Disease Market, by Country
2.2.2.1.1 U.K.
2.2.2.1.2 France
2.2.2.1.3 Germany
2.2.2.1.4 Italy
2.2.2.1.5 Spain
2.2.2.1.6 Rest of Europe
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Celiac Disease Market, by Country
2.3.2.1.1 Japan
2.3.2.1.2 Rest of Ais-Pacific
2.4 Rest of the World
2.4.1 Market Dynamics
2.4.2 Market Sizing and Forecast
3. Global Celiac Disease Market, Competitive Landscape and Company Profiles
3.1 Competitive Landscape
3.1.1 Mergers and Acquisitions
3.1.2 Partnership, Alliances and Business Expansion
3.1.3 New Offerings
3.1.4 Regulatory Activities
3.1.5 Funding Activities
3.2 Company Profiles
3.2.1 Takeda Pharmaceutical Company Limited
3.2.1.1 Overview
3.2.1.2 Top Products / Product Portfolio
3.2.1.3 Top Competitors
3.2.1.4 Target Customers/End-Users
3.2.1.5 Key Personnel
3.2.1.6 Analyst View
3.2.2 Sanofi
3.2.2.1 Overview
3.2.2.2 Top Products / Product Portfolio
3.2.2.3 Top Competitors
3.2.2.4 Target Customers/End-Users
3.2.2.5 Key Personnel
3.2.2.6 Analyst View
3.2.3 Entero Therapeutics, Inc.
3.2.3.1 Overview
3.2.3.2 Top Products / Product Portfolio
3.2.3.3 Top Competitors
3.2.3.4 Target Customers/End-Users
3.2.3.5 Key Personnel
3.2.3.6 Analyst View
3.2.4 Anokion SA
3.2.4.1 Overview
3.2.4.2 Top Products / Product Portfolio
3.2.4.3 Top Competitors
3.2.4.4 Target Customers/End-Users
3.2.4.5 Key Personnel
3.2.4.6 Analyst View
3.2.5 Allero Therapeutics
3.2.5.1 Overview
3.2.5.2 Top Products / Product Portfolio
3.2.5.3 Top Competitors
3.2.5.4 Target Customers/End-Users
3.2.5.5 Key Personnel
3.2.5.6 Analyst View
3.2.6 Mozart Therapeutics
3.2.6.1 Overview
3.2.6.2 Top Products / Product Portfolio
3.2.6.3 Top Competitors
3.2.6.4 Target Customers/End-Users
3.2.6.5 Key Personnel
3.2.6.6 Analyst View
3.2.7 Pfizer
3.2.7.1 Overview
3.2.7.2 Top Products / Product Portfolio
3.2.7.3 Top Competitors
3.2.7.4 Target Customers/End-Users
3.2.7.5 Key Personnel
3.2.7.6 Analyst View
3.2.8 Teva Pharmaceuticals
3.2.8.1 Overview
3.2.8.2 Top Products / Product Portfolio
3.2.8.3 Top Competitors
3.2.8.4 Target Customers/End-Users
3.2.8.5 Key Personnel
3.2.8.6 Analyst View
3.2.9 Immunic Therapeutics
3.2.9.1 Overview
3.2.9.2 Top Products / Product Portfolio
3.2.9.3 Top Competitors
3.2.9.4 Target Customers/End-Users
3.2.9.5 Key Personnel
3.2.9.6 Analyst View
4. Research Methodology
List of Figures
Figure: Global Celiac Disease Market Coverage
Figure: Global Celiac Disease Market Key Trends, Impact Analysis, 2023-2035
Figure: Global Celiac Disease Market, Patent Analysis, January 2022-March 2025
List of Tables
Table: Global Celiac Disease Market, Market Dynamics, Impact Analysis, 2023-2035
Table: Global Celiac Disease Market (by Region), $Million, 2023-2035

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us